Key Takeaways
- Record quarter, margin reset: Revenue and EBITDA hit all-time highs, but EBITDA margin compressed to 13.1% as the company deliberately pushed volumes and absorbed a sharp drop in high-margin AHN business.
- Volume-over-margin is now explicit strategy: Management stated it will no longer focus on EBITDA percentage, only on absolute EBITDA amount, signaling the margin reset is structural for the near term.
- Capacity constraints capped the quarter: Unitop and Tristar ran at near-100% utilization, causing lost orders in July and August; two large CAPEX projects aim to relieve this, but commissioning is 18 months out.
- Textile and AHN remain drags with uncertain timelines: Textile demand is muted and Bangladesh business has shrunk to one-third of last year on credit caution; AHN dropped 30-35% YoY. Recovery in both is hoped for, not committed.
- What to watch next quarter: Whether the volume push sustains revenue momentum into H2, any stabilization in textile and AHN volumes, and the pace of working capital normalization from the elevated 98 days.
Performance Drivers & Headwinds
- HPPC led the record: Home & Personal Care and Performance Chemicals (coatings, paint, water treatment, paper, ceramic) drove growth, with past customer seeding in homecare now converting to revenue.
- Capacity utilization ran hot: Dahej at 77-80%, while Unitop and Tristar were practically at 100%, forcing the company to turn away orders in July and August that would have made the quarter stronger.
- AHN collapse hit mix hard: The Animal Health & Nutrition business fell 30-35% YoY, driven by seasonal softness, muted demand, and a deliberate pullback from feeds business where customer payment issues emerged. This is a high gross margin segment, so its decline disproportionately hurt margins.
- Textile chemicals stayed weak: Two quarters of headwinds persist, with US consumer discretionary spending on textiles not picking up, higher interest rates biting, and COVID-era subsidies ended. Management called the demand outlook unclear.
- Bangladesh business deliberately shrunk: The company chose to forego business rather than extend open credit terms amid forex issues in Bangladesh; the business is now one-third of last year's level. No bad debts in 26 years, and management intends to keep it that way.
- Agro surfactants held ground: Prices stabilized, but a 10-12 day disruption in EO supply from the Nagori plant and a weak agrochemical season created headwinds. Export market expansion is the planned growth lever.
- Other expenses stepped up: A ₹10 crore QoQ increase in other expenses reflected maintenance at Unitop and Rossari plants, higher utility consumption, and increased selling and distribution costs from travel and exhibitions. Management said this is not one-off and the half-yearly run rate of ₹88 crore is the right baseline.
Chari: "We lost some orders because we did not have adequate capacity to service those orders. Otherwise, our quarter would have been more stronger."
Margin Strategy Reset
- EBITDA amount, not percentage: Management explicitly abandoned EBITDA margin percentage as a metric, stating the focus is now solely on absolute EBITDA. The ₹63 crore quarterly EBITDA was the highest ever, and that is the number the company wants investors to track.
- Three-part margin compression: The 13.1% EBITDA margin reflects (1) volume push with some pricing sacrifice, (2) the 30-35% drop in high-margin AHN business, and (3) higher other expenses from maintenance, utilities, and selling costs.
- Near-term floor guided: Management expects similar margin levels at least through the end of FY24, with no near-term expansion promised.
- ROCE debate: An analyst noted ROCE has declined from ~40% at IPO to under 20%. Management countered that ROCE has been constant at 20-23%, currently at 22-23%, and increased QoQ. The gap between these narratives is unresolved.
- Return ratio recovery tied to new CAPEX: Management expects ROCE to peak back to 23-24% once new CAPEX comes on stream and reaches substantial utilization, roughly two years out.
Chari: "We are now not focusing on margins as percentage at all. I think all of us should be happy that at Rs. 63 crore of EBITDA, we have the highest EBITDA ever. So, we would only focus on our EBITDA as an amount rather than EBITDA as a percentage. We will not be looking at EBITDA as a percentage in the future."
Capacity Expansion
- Two large projects announced: A 20,000 MTPA expansion at Dahej for new HPPC domains and subsidiary ingredients, and a 30,000 MTPA ethoxylation capacity addition at Unitop Dahej, where existing 36,000 MTPA is at optimal levels.
- Total CAPEX outlay: ₹178 crore, split as ₹50 crore for Dahej and ₹128 crore for Unitop ethoxylation. FY24 spend expected at ₹125-130 crore, balance in FY25.
- Commissioning timeline: Both projects anticipated by Q3 FY25, executed in phased manner. Some ethoxylation phases will come online over the next 6 months.
- Revenue contribution expected: The ₹180 crore CAPEX should contribute roughly ₹400 crore in revenue in the first 1 to 1.5 years, with peak asset turn of 4 to 4.5x around the 4-year mark. At full peak capacity over 2-4 years, incremental revenue could reach about ₹600 crore.
- Funding mix: Balanced blend of internal accruals and external borrowings; nothing finalized yet, but management is comfortable even if the entire amount is debt-funded.
- Physical space available: 19 acres at Unitop site plus adequate space at Rossari; attempts to acquire neighboring land at Unitop have not yet succeeded.
Working Capital & Balance Sheet
- Working capital spiked to 98 days: Up from 79 days in March, driven by strong agro off-take with long payment cycles, major institutional sales in Q2 with extended credit terms, and deliberate inventory build-up of key raw materials for Q3 production planning.
- Target normalization: Management acknowledged the level is slightly elevated due to seasonality, expects it to even out, and is targeting 85-90 days going forward.
- Forex hedge is natural: Many raw materials at Unitop are imported, but exports are nearly 1.5x of imports, providing a natural hedge without needing active forex management.
- Raw material sourcing shift: Acrylic acid now sourced mostly domestically from the BPCL plant; acetic acid balanced between GNFC and imports.
Segment-Level Moves & Bets
- Textile chemicals restructuring: Rossari Bangladesh incorporated, two senior leaders added to the Bangladesh team, and a new leader appointed for textiles within the organization. Focus markets are domestic and Bangladesh, with Turkey and Egypt under watch but uncertain due to geopolitics.
- Textile demand bet: Management expressed positivity for textile business from January 1, 2024, but did not tie this to any confirmed demand signal, and separately noted US consumer spending on textiles remains weak and the outlook unclear.
- Animal Health caution: No major concern on the business itself, but management is cautious on total outstanding in the market. The double Shraavan period and poultry industry focus were cited as context. The stated view is AHN "should do well in future" without a timeline.
- Agro surfactants export push: With domestic agrochemical season weak, the company is looking at export markets for growth.
- Bangladesh forex watch: If forex problems get resolved, management sees pretty good demand from Bangladesh in the coming year, but this is conditional and uncommitted.
Chari: "We are prepared to forego business rather than risk our capital. We do not have bad debts in our systems for the past 26 years and we do not want to in the future also."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin level | Similar margins to current 13.1-13.5% | At least through end of FY24 |
| Dahej + Unitop CAPEX commissioning | 20,000 MTPA + 30,000 MTPA projects completed | Q3 FY25, phased |
| FY24 CAPEX spend | ₹125-130 crore of ₹178 crore total | FY24 |
| Incremental revenue from new CAPEX | ~₹400 crore in first 1-1.5 years; ~₹600 crore at peak | 1-4 years from commissioning |
| ROCE recovery | Peak back to 23-24% | ~2 years, once new CAPEX reaches substantial utilization |
| Working capital days | Normalize to 85-90 days | Going forward, no specific quarter |
| Textile business improvement | Positive outlook | From January 1, 2024 |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Consolidated revenue | ₹483.5 crore, +14% YoY |
| HPPC segment growth | 22% YoY, led by Agro, Phenoxy, Institutional Cleaning, Paints, Home & Personal Care |
| Textile Speciality Chemicals growth | 5% YoY |
| AHN segment performance | Down 30% to 35% YoY, due to seasonal variation and reduced feeds business |
| EBITDA | ₹63.6 crore, +13% YoY from ₹56.5 crore in Q2 FY23 |
| EBITDA margin | 13.1%, vs 13.5% in H1 FY24; management prioritizing volume and utilization over margin percentage |
| PAT | ₹32.9 crore, +38% YoY from ₹23.9 crore in Q2 FY23 |
| H1 FY24 revenue | ₹900 crore, vs ₹350 crore in H1 FY20, nearly 3x growth in 3 years |
| H1 FY24 EBITDA | ₹121 crore |
| H1 FY24 PAT | ₹62 crore |
| Net debt-to-equity ratio | 0.05x as of September 2023 |
| Working capital days | 98 days as of September 2023, vs 79 days in March 2023; targeted 85 to 90 days going forward |
| ROCE | 23%, management states it has been constant between 20% to 23% and has not declined |
| Capacity utilization – Dahej (Rossari) | 77% to 80% |
| Capacity utilization – Unitop and Tristar | Nearing 100% in the last quarter |
| Unitop YoY growth | About 25% |
| Tristar YoY growth | About 18% to 20% |
| Total announced CAPEX | ₹178 crore (₹50 crore for Rossari Dahej expansion, ₹128 crore for Unitop Ethoxylation expansion) |
| CAPEX spent in H1 FY24 | ₹75 crore, across ETP, tank farms, debottlenecking, solar, maintenance, and brand purchases |
| Full-year FY24 CAPEX estimate | Around ₹125-130 crore |
| Dahej expansion capacity addition | 20,000 MTPA |
| Ethoxylation capacity addition (Unitop) | 30,000 MTPA, augmenting existing 36,000 MTPA |
| New CAPEX revenue potential | Roughly ₹400 crore in top line in first 1 to 1.5 years; peak asset turn of 4 to 4.5x around the 4-year mark |
| Bangladesh textile business | Down to one-third of last year's level, due to cautious credit terms |